Pulmonx Statistics
Total Valuation
Pulmonx has a market cap or net worth of $61.46 million. The enterprise value is $41.47 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pulmonx has 41.25 million shares outstanding. The number of shares has increased by 3.66% in one year.
| Current Share Class | 41.25M |
| Shares Outstanding | 41.25M |
| Shares Change (YoY) | +3.66% |
| Shares Change (QoQ) | +1.25% |
| Owned by Insiders (%) | 2.37% |
| Owned by Institutions (%) | 74.77% |
| Float | 40.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.65 |
| Forward PS | 0.62 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.86, with a Debt / Equity ratio of 0.94.
| Current Ratio | 4.86 |
| Quick Ratio | 3.97 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.72 |
Financial Efficiency
Return on equity (ROE) is -73.73% and return on invested capital (ROIC) is -26.84%.
| Return on Equity (ROE) | -73.73% |
| Return on Assets (ROA) | -23.38% |
| Return on Invested Capital (ROIC) | -26.84% |
| Return on Capital Employed (ROCE) | -49.55% |
| Revenue Per Employee | $314,997 |
| Profits Per Employee | -$195,027 |
| Employee Count | 291 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.47 |
Taxes
In the past 12 months, Pulmonx has paid $478,000 in taxes.
| Income Tax | 478,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.83% in the last 52 weeks. The beta is 0.21, so Pulmonx's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -77.83% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 3.70 |
| Relative Strength Index (RSI) | 41.21 |
| Average Volume (20 Days) | 6,850,994 |
Short Selling Information
The latest short interest is 2.35 million, so 5.71% of the outstanding shares have been sold short.
| Short Interest | 2.35M |
| Short Previous Month | 1.42M |
| Short % of Shares Out | 5.71% |
| Short % of Float | 5.85% |
| Short Ratio (days to cover) | 0.45 |
Income Statement
In the last 12 months, Pulmonx had revenue of $91.66 million and -$56.75 million in losses. Loss per share was -$1.41.
| Revenue | 91.66M |
| Gross Profit | 67.19M |
| Operating Income | -57.18M |
| Pretax Income | -56.28M |
| Net Income | -56.75M |
| EBITDA | -56.06M |
| EBIT | -57.18M |
| Loss Per Share | -$1.41 |
Full Income StatementBalance Sheet
The company has $76.55 million in cash and $56.56 million in debt, giving a net cash position of $19.99 million or $0.48 per share.
| Cash & Cash Equivalents | 76.55M |
| Total Debt | 56.56M |
| Net Cash | 19.99M |
| Net Cash Per Share | $0.48 |
| Equity (Book Value) | 60.03M |
| Book Value Per Share | 1.46 |
| Working Capital | 88.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$32.02 million and capital expenditures -$550,000, giving a free cash flow of -$32.57 million.
| Operating Cash Flow | -32.02M |
| Capital Expenditures | -550,000 |
| Free Cash Flow | -32.57M |
| FCF Per Share | -$0.79 |
Full Cash Flow StatementMargins
Gross margin is 73.30%, with operating and profit margins of -62.38% and -61.91%.
| Gross Margin | 73.30% |
| Operating Margin | -62.38% |
| Pretax Margin | -61.39% |
| Profit Margin | -61.91% |
| EBITDA Margin | -61.16% |
| EBIT Margin | -62.38% |
| FCF Margin | n/a |
Dividends & Yields
Pulmonx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.66% |
| Shareholder Yield | -3.66% |
| Earnings Yield | -92.34% |
| FCF Yield | -53.00% |
Analyst Forecast
The average price target for Pulmonx is $6.81, which is 357.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.81 |
| Price Target Difference | 357.05% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 28.24% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pulmonx has an Altman Z-Score of -3.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.62 |
| Piotroski F-Score | 3 |
